Home health aides flattened the curve by keeping the most vulnerable patients — seniors, the disabled, the infirm — out of hospitals. But they’ve done it mostly at poverty wages and without overtime pay, hazard pay, sick leave or health insurance.
Read MoreInstrumentalists in ensembles, marching bands and other groups are getting creative with pantyhose, air filters, fabric and sewing machines to reduce the risk of COVID without silencing the music.
Read MoreMore than 50% of people said they favor Democratic presidential candidate Joe Biden’s approach to an array of health issues.
Read MoreThe World Health Organization has been consistent throughout the pandemic in communicating that lockdowns should be employed only when COVID-19 cases are high — to give governments and health systems time to redouble efforts. Forced closures should not be the primary strategy to combat coronavirus transmission.
Read MoreBarring something unexpected, Democrats in the Senate appear to lack the votes to block the confirmation of Judge Amy Coney Barrett to the Supreme Court. So, instead they used the high-profile confirmation hearings to hammer on Republicans for again putting the Affordable Care Act in peril. Mary Ellen McIntire of CQ Roll Call, Shefali Luthra of The 19th and Sarah Karlin-Smith of Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews Dr. Ashish Jha, dean of the Brown University School of Public Health, about public health challenges in dealing with COVID-19.
Read MoreReports are on the rise regarding excruciating headaches, stomach upsets for weeks on end, sudden outbreaks of shingles and flare-ups of autoimmune disorders. A common thread among the complaints, one that has been months in the making, is chronic stress.
Read MoreRather than prosecuting their case against Supreme Court nominee Amy Coney Barrett, Democrats on the Senate Judiciary Committee are refighting the war that won them seats in 2018 — banging on Republicans for trying to eliminate the Affordable Care Act.
Read More
Strict enforcement of coronavirus protocols at factories and shops where some of the worst outbreaks have occurred has reduced the racial and ethnic disparities in COVID deaths and illness, say public health officials. They want to expand the effort by creating workplace safety councils.
Read MoreRetirement areas are increasingly being built in the idyllic wooded fringe of towns and cities. Being close to nature also means being in the path of wildfires.
Read More
A new chain of stores is spreading in malls across America, just like the disease that is giving it business. COVID-19 Essentials is selling masks and all the gear needed to stay safe — and the owner can’t wait to go out of business.
Read More
Although it used to be thought that the majority of children with atopic dermatitis, or eczema,...
Read MoreNo overall differences in the functional diversity of the gut microbiome were found in patients with pediatric-onset MS in a study using metagenomic sequencing. However, there were differences in the functional potential...
Read MoreInterim results from two phase 2 studies provide evidence that orally delivered CNM-Au8 (gold nanocrystals) have catalytic effects on key bioenergetic metabolites in the brain of patients with MS and Parkinson’s disease...
Read MoreThe presence of cardiovascular (CV) risk factors is associated with brain atrophy in relatively young MS patients under the age of 50. CV risk factors seem to have synergistic effects in MS. CV risk factors have been associated...
Read MoreCerebrospinal fluid (CSF) tau and beta-amyloid (Aβ) proteins are among the biomarkers currently applied in other neurodegenerative diseases than MS. Partly due to conflicting results, not a single biomarker of axonal damage in...
Read MoreAn Italian study showed that long-term disability outcomes were more favourable with a strategy of early intensive treatment (EIT) than with moderate-efficacy treatment followed by escalation to higher-efficacy treatment (ESC)....
Read MoreResults of a Spanish two-center study suggest that low doses of rituximab are equally effective as high doses, but have a superior safety profile. The anti-CD20 monoclonal antibody rituximab is not registered for the treatment...
Read MoreOfatumumab Shows Efficacy & Safety in New MS Patients Only a few weeks prior to MSVirtual2020, the fully human anti-CD20 monoclonal antibody ofatumumab was approved by the FDA for the treatment of relapsing multiple...
Read More
While respiratory issues are a well-documented symptom of coronavirus, researchers have found that...
Read MoreA Global Data Sharing Initiative study reported that multiple sclerosis (MS) patients taking certain anti-CD20 disease modifying therapies (DMTs), specifically ocrelizumab or rituximab, with suspected or confirmed COVID-19 have...
Read More
